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The concept of pseudomelanocytic nests has been recently described in the dermatology literature. To our
knowledge, this entity has yet to be published in the oral pathology literature. We report 2 cases with features of
pseudomelanocytic nests. In both instances, nests of cells suspicious for melanocytes were observed. Interpretation of melan-A
was negative. Both cases showed strong and diffuse immunoreactivity of the nested cells to CD68. This immunohistochemical
staining pattern is most consistent with a melanophage identity. Pseudomelanocytic nests are a recently described entity that
represents a potential diagnostic pitfall. Distinguishing pseudomelanocytic nests from an authentic atypical melanocytic
proliferation can be challenging and is important for appropriate patient management. Clinicopathologic correlation with
cautious interpretation of immunohistochemistry may be necessary to arrive at the correct diagnosis. These cases represent the
first reports of pseudomelanocytic nests in the oral pathology literature. (Oral Surg Oral Med Oral Pathol Oral Radiol 2014;
118:461-468)Oral mucosal melanoma accounts for less than 1% of
melanomas, affecting approximately 1 in 2 million
people annually in the United States.1,2 Oral melanomas
aremore common in individuals over 40 years of age, and
a slight male predilection is observed. Risk factors for
oral melanoma are less well characterized than those for
cutaneousmelanoma. In general, fair-skinned individuals
are at increased risk for developing cutaneous melanoma.
Although an increased frequency of oral melanomas has
been reported in Japanese and Ugandan Africans, this
may be relative to the lower incidence of cutaneous
melanomas in these populations.1,2
High-risk sites for oral mucosal melanomas are the
hard palate and maxillary gingiva.1,2 In a literature review
by Rapini et al.,2 75% of cases occurred at the afore-
mentioned locations. The majority of oral mucosal mel-
anomas are most similar to the acral lentiginous subtype
of cutaneousmelanoma.1 Between 30%and 37% of cases
are associated with a preexisting pigmented lesion.2 This
likely represents the radial growth phase of the neoplasm
and less likely represents a melanoma arising from a
discrete preexisting benign melanocytic lesion. The
majority of oral melanomas exhibit early invasive char-
acteristics.3 Pigmented lesions of the oral cavity that
cannot be deﬁnitively diagnosed clinically and radio-
graphically should be biopsied for deﬁnitive diagnosis.
Melanocytic hyperplasia is deﬁned as increased
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Open access under CC BY-NC-ND license.the epithelium in the absence of signiﬁcant conﬂuence,
nesting, or pagetoid spread.4 A ratio of 1 melanocyte
per 10 basal keratinocytes is generally accepted as
normal, although this ratio is dependent on anatomic
location.4 Atypical melanocytic proliferations may
represent the proliferative phase of a melanocytic
neoplasm before malignant transformation occurs,
making early diagnosis critical for survival.3,5 As
deﬁned by the WESTOP (Western Society of Teachers
of Oral Pathology) Banff Workshop on oral mela-
nomas, atypical melanocytic proliferations represent
melanocytic lesions in which the microscopic archi-
tecture or cytology is equivocal.3 Cellular features of
melanocytic atypia include angular and hyperchromatic
nuclei and cells with very infrequent mitotic activity.3
Although sometimes used synonymously with atypical
melanocytic proliferation, melanoma in situ should be
reserved for morphologically malignant lesions that are
incapable of metastasis.6
The concept of pseudonests, or more precisely pseu-
domelanocytic nests, has been reported in the derma-
tology literature.7 This entity is signiﬁcant because it
represents a potential diagnostic pitfall, given that the
histologic differential diagnoses include atypical mela-
nocytic proliferations, melanoma in situ, and lentigo
maligna melanoma.7-9 Not only is the routine histopa-
thology difﬁcult to interpret, but a potential for error exists
in the interpretation of immunohistochemical analysis of
these lesions.7-9 The cells that constitute the pseudome-
lanocytic nests have not been fully characterized. Based
on immunohistochemical analysis, macrophages appear
to be a predominant cell type. Occasional lymphocytes,
melanocytes, degenerated keratinocytes, or a combina-
tion of those may or may not be present in the nests.
Pseudomelanocytic nests have been described in the
setting of ﬁxed drug eruptions, lichen planus pigmento-
sus, and lichenoid lesions including lichenoid keratosis461
Fig. 1. Clinical photograph depicting a slightly elevated,
pigmented lesion of the facial interdental papilla between the
mandibular central incisors (case 1, lesion 1).
Fig. 2. Low-power photomicrograph of the pigmented lesion
in Figure 1. The section shows a somewhat nodular lesion
covered by nondysplastic stratiﬁed squamous epithelium.
Aggregates of nested cells are present. Scattered foci of
chronic inﬂammation, some of which is perivascular in nature,
are observed in the lamina propria and superﬁcial connective
tissue stroma (case 1, lesion 1; hematoxylin-eosin, original
magniﬁcation  4). (A high-resolution version of the image is
available as eSlide: VM00243.)
Fig. 3. Medium-power photomicrograph of the pigmented
lesion in Figure 1. Some of the nested cells have enlarged and
hyperchromatic nuclei for melanocytes (case 1, lesion 1;
hematoxylin-eosin, original magniﬁcation  10). (A high-reso-
lution version of the image is available as eSlide: VM00243.)
Fig. 4. High-power photomicrograph of the pigmented lesion.
Some of the nested cells have enlarged, irregular nuclei (case
1, lesion 1; hematoxylin-eosin, original magniﬁcation  40).
(A high-resolution version of the image is available as eSlide:
VM00243.)
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prognosis for these reactive lesions are different
compared with those for atypical melanocytic prolifera-
tion, melanoma in situ, and lentigo maligna melanoma;
thus, distinction between these lesions is essential. To our
knowledge, the present cases are the ﬁrst 2 reported cases
of pseudomelanocytic nests in the oral pathology
literature.
CASE REPORT
Case 1
A 66-year-old man presented to a private periodontist’s ofﬁce
for evaluation of a slightly elevated pigmented lesion of the
facial interdental papilla between the mandibular central in-
cisors (Figure 1). A sudden onset of the lesion was reported.
The remainder of the oral examination was within normallimits. No clinical evidence of lichen planus or lichenoid
mucositis was observed. The patient’s medical history was
noncontributory. No medications, prescribed or otherwise,
were reported. The social history was negative for smoking. A
biopsy of the lesion was performed.
The initial interpretation of this lesion was that of an
atypical melanocytic proliferation (Figures 2 to 4). The
atypical preﬁx was in reference to the perceived abnormal
nesting pattern in combination with the nuclear features of
these cells. Occasional nuclei in these nested cells were
interpreted as enlarged with irregular nuclear contours for
Fig. 5. A, Melan-A staining in nested cells was comparable
with the negative control (slide not available). Focal weak
cytoplasmic staining was present which was interpreted as
non-speciﬁc. A positive internal control highlighting melan-A
immunoreactivity in the nuclei and cytoplasmic extensions
of melanocytes in the basal cell layer is present (case 1, lesion
1; original magniﬁcation  10). (A high-resolution version of
the image is available as eSlide: VM00244.) B, Medium-
power photomicrograph of the same area as seen in panel
A. The nested cells show strong, diffuse immunoreactivity
to CD68 (case 1, lesion 1; original magniﬁcation  10). (A
high-resolution version of the image is available as eSlide:
VM00246.)
Fig. 6. Clinical photograph depicting a nonuniformly pig-
mented lesion with irregular borders of the buccal gingiva
associated with the left maxillary second molar. (case 1,
lesion 2).
OOOO CASE REPORT
Volume 118, Number 4 Boros, Handlers and Melrose 463typical melanocytes. No mitotic activity was identiﬁed within
these cells. A mild chronic inﬂammatory inﬁltrate was pre-
sent in the lamina propria and superﬁcial connective tissue. A
provisional diagnosis of atypical melanocytic proliferation
was rendered. The slides were sent for consultation to an
outside oral and maxillofacial pathology group. Blind to the
contributor’s diagnosis, 2 oral and maxillofacial pathologists
independently diagnosed the lesion as an atypical melano-
cytic proliferation.
In an attempt to better examine the extent of the melanocytic
component, melan-A/MART-1 (melanoma antigen recognized
by T cells 1) immunohistochemistry was performed with
appropriate positive and negative controls. This stain high-
lighted individual melanocytes along the length of the basal cell
layer. Melan-A in nested cells (Figure 5, A) was comparable
with the negative control (slide not available). Focal weak
cytoplasmic staining was present which was interpreted as non-
speciﬁc. Based on the hematoxylin-eosin interpretation, the
diagnosis remained unchanged. A comment was provided
suggesting that the patient be placed on close and continued
follow-up, with a recommendation to perform another biopsy
for any new or recurrent pigmented lesions. At this time, a CD68
stain was not performed.
Approximately 2 months later, the patient returned to the
same ofﬁce with a second pigmented lesion. The second
lesion was located on the buccal gingiva associated with the
maxillary left second molar (Figure 6). Another biopsy wasperformed. A similar microscopic pattern was observed and,
once again, a diagnosis of atypical melanocytic proliferation
was rendered (Figure 7). The slide was sent for consultation.
All oral and maxillofacial pathologists were in agreement with
the initial diagnosis. Immunohistochemistry for melan-A
found a staining pattern similar to the previous biopsy
(Figure 8, A), and the diagnosis remained unchanged. At this
time, CD68 analysis was not performed. Ten days later, pig-
mented lesions of the right hard palate adjacent to the
maxillary second molar and several pigmented lesions of the
lower lip were also noted.
At the request of the patient, material from the biopsies was
sent for a consultative opinion at an outside institution where
interpretation was performed in conjunction with the Depart-
ment of Dermatopathology. At this time, immunohistochem-
istry for CD68 was performed on both biopsies (Figures 5, B,
and 8, B). The nested cells stained strongly positive for CD68.
Immunohistochemical stains for melan-A, MiTF (micro-
pthalmia-associated transcription factor), and SOX10 (sex-
determining region Y box 10) were interpreted as negative
(immunohistochemistry not available for MiTF and SOX10).
Although the diagnosis of atypical melanocytic proliferation
was in the differential diagnosis, with this additional informa-
tion, both lesions were interpreted as “chronic mucositis with
pseudomelanocytic nests.”
Fig. 8. A, Melan-A in nested cells was comparable with the
negative control (slide not available). Focal cytoplasmic
staining was present which was interpreted as non-speciﬁc
(case 1, lesion 2; original magniﬁcation  10). (A high-res-
olution version of the image is available as eSlide:
VM00247.) B, Medium-power photomicrograph of the same
area of the lesion as seen in panel A. The nested cells show
immunoreactivity to CD68 (case 1, lesion 2; original
magniﬁcation  10). (A high-resolution version of the image
is available as eSlide: VM00248.)
Fig. 9. Medium-power photomicrograph showing nests of
cells, some of which contain cytoplasmic melanin in a back-
ground of mild chronic inﬂammation (case 2; hematoxylin-
eosin, original magniﬁcation  10). (A high-resolution
version of the image is available as eSlide: VM00239.)
Fig. 7. Medium-power photomicrograph showing a similar
histology to the patient’s ﬁrst biopsy. A collection of nested
cells is highlighted. Melanin pigment is noted. A mild chronic
inﬂammatory inﬁltrate is present in the superﬁcial connective
tissue (case 1, lesion 2; original magniﬁcation  10). (A high-
resolution version of the image is available as eSlide:
VM00245.)
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The second case was received in consultation from Keck
Hospital at the University of Southern California Department
of Pathology. The medical history was noncontributory. No
medications, prescribed or otherwise, were reported. Clinical
examination of a 61-year-old female disclosed a pigmented
lesion of the hard palate; a biopsy was performed. Histopa-
thology revealed squamous hyperplasia with hyperkeratosis
and spongiosis with mild exocytosis. Associated with the
epithelium were nests of cells, suspicious for melanocytes(Figure 9). There was concern that this lesion may represent
an atypical melanocytic proliferation. Upon review of the
slides at Oral Pathology Associates Inc, melan-A (Figure 10,
A) was comparable with the negative control (eSlide:
VM00240). Focal cytoplasmic staining was present which
was interpreted as non-speciﬁc. The consulting pathologist
suggested that immunohistochemistry for CD68 be per-
formed to help clarify the nature of the cells constituting the
nests. These nested cells were strongly positive for CD68
(see Figure 10, B). They were subsequently interpreted as
melanophages constituting pseudomelanocytic nests.DISCUSSION
Maize et al.7 were the ﬁrst to publish the term pseu-
domelanocytic nests in the dermatology literature. They
described a case initially diagnosed as a partially
regressed melanocytic neoplasm worrisome for mela-
noma in situ, in which melan-A was interpreted as
positive. Owing to a clinicopathologic disconnect, the
contributing clinician performed a second biopsy.
Histopathologically it was similar to the ﬁrst lesion.
Additional immunohistochemical analyses found
nested cells negative for S100 and HMB45 (human
melanoma black 45), which did not support cells of
melanocytic origin. A subsequent diagnosis of interface
dermatitis with “pseudonests” was rendered.7 After
clinical correlation, a diagnosis of discoid lupus
erythematosus was favored.
Subsequently, 3 cases of lichenoid dermatitides with
pigmentation, initially diagnosed as melanoma in situ,
were reported.8 In each case, melan-A staining was
initially performed and interpreted as positive in the
nested cells. Further analysis found negativity for S100
and HMB45. Focal nested cells were positive for pan-
cytokeratin. The authors cautioned against the isolated
Fig. 10. A, Immunohistochemical stain for melan-A was
similar to the negative control. Focal cytoplasmic staining was
present which was interpreted as non-speciﬁc. A positive in-
ternal control highlighting melan-A immunoreactivity in the
nuclei and cytoplasmic extensions of melanocytes in the basal
cell layer is present (case 2; original magniﬁcation  10). (A
high-resolution version of the image is available as eSlide:
VM00240.) B, Medium-power photomicrograph of the same
area of the lesion as seen in panel A. The nested cells show
strong, diffuse immunoreactivity to CD68 (case 2; original
magniﬁcation  10). (A high-resolution version of the image is
available as eSlide: VM00241.) (A high-resolution image of a
negative control for this case is available as eSlide: VM00242.)
OOOO CASE REPORT
Volume 118, Number 4 Boros, Handlers and Melrose 465use of melan-A in the evaluation of potential melano-
cytic lesions.
Shortly thereafter, Nicholson et al.9 contributed 2
similar cases, which were originally diagnosed as len-
tigo maligna melanoma but were reclassiﬁed as ﬁxed
drug eruptions after clinicopathologic correlation.
Again, initial immunohistochemical analysis limited to
melan-A/MART-1 found cytoplasmic staining in nested
cells, which in combination with the histopathology
prompted the diagnosis of lentigo maligna melanoma.
Subsequent immunohistochemical tests found S100,
HMB45, and MiTF negativity. Further characterization
for nested cells found focal positivity for CD3 and
AE1/AE3. In addition, 1 case highlighted focal CD68
immunoreactivity of nested cells.
The 6 aforementioned cases involved lesions of the
skin affecting the head and neck, a location which is of
signiﬁcance to the oral health care professional. A po-
tential relationship to chronic sun exposure has been
suggested,8 but this is likely not applicable to oral le-
sions. Including the present cases, men and women
have been affected equally. Patients range in age from
35 to 76 years (average, 56 years). Pigmented lesionshave been both solitary and multiple. In all cases, astute
correlation of the histopathology, immunohistochem-
istry, and clinical presentation was necessary to arrive
at the correct diagnosis. Table I provides a summary of
published cases of pseudomelanocytic lesions with
initial interpretations ranging from atypical melanocytic
neoplasms to lentigo maligna melanoma.
The histopathologic characteristics of the present
cases included nests of cells in a background of a var-
iable chronic inﬂammatory inﬁltrate. Pigment was pre-
sent within nested cells and within cells in the lamina
propria. Based on histopathology alone, it may be
difﬁcult to differentiate atypical melanocytic pro-
liferations from pseudomelanocytic nests. Immunohis-
tochemical analysis plays an important role in the
accurate diagnosis of these lesions.
CD68 (KP1) is located on lysosomes and therefore is
not entirely cell lineage speciﬁc. Despite this, it
is generally regarded as a marker for cells of the
macrophage lineage. Positivity has been reported in
other cell types, including ﬁbroblasts. A wide range of
neoplasms, both histiocyte-related and non-histiocyte-
related, have reported immunoreactivity with CD68.
Pernick et al.10 published a series of melanoma cases
that exhibited weak staining for CD68. The intensity of
staining (strong or weak) is generally accepted to be an
important indicator of cell type, with cells of the
macrophage lineage staining strongly for CD68.
Melan-A/MART-1, commonly used as a marker for
melanocytes, is not as speciﬁc as once believed. Both
melan-A/MART-1 and HMB45 target components of
the melanosome. These components may be transferred
to nonmelanocytic cells, including cells of the macro-
phage lineage, resulting in nonspeciﬁc cytoplasmic
staining.7-9 Cytoplasmic melan-A and HMB45 staining
is not necessarily synonymous with a melanocytic
identity, highlighting the hazard of relying primarily on
these immunohistochemical stains for diagnosis, espe-
cially when performed in isolation.
MiTF is a more speciﬁc melanocytic marker that
targets a nuclear transcription factor within melano-
cytes,11 resulting in a nuclear staining pattern. However,
recent reports also indicate that MiTF is not entirely
speciﬁc for melanocytes and may also react with com-
ponents of macrophages and mast cells.12 A case of
pseudomelanocytic nests with rare positivity for MiTF
and SOX10 in the setting of lichenoid inﬂammation has
been reported.12 In this case, clinicopathologic correla-
tion prevented initial misdiagnosis. To explain these
results, Silva et al.12 entertained the possibility of either
a new melanocytic entity or a distinct pattern of benign
melanocytic reorganization in the setting of lichenoid
dermatitides. Additional studies are needed for further
clariﬁcation. In these instances, CD68 also may help
characterize the nested cells.
Table I. Reported cases of pseudomelanocytic nests initially interpreted as melanocytic lesions
Case Reference Age/Sex Clinical presentation Initial interpretation Final interpretation IHC
1 Maize et al.7 35/M Recent onset of blue-gray
macules on left temple
Partially regressed
melanocytic neoplasm
worrisome for
melanoma in situ with
marked regression
Interface dermatitis with
“pseudonests”; clinical
correlation favored a
ﬁnal diagnosis of
discoid lupus
erythematosus
MAþ
S100L
BCl2L
TYRL
HMB45L
2 Beltraminelli et al.8 60/M Poorly deﬁned brown-
grayish pigmentation
on cheek; clinical
impression “lentigo;
rule out lentigo
maligna”
Melanoma in situ Lichenoid phototoxic
reaction on sun-
damaged skin with
melan-A-positive
pseudomelanocytic
nests
MAþ
S100L
HMB45L
AE±
3 Beltraminelli et al.8 59/M Irregular, partly conﬂuent,
reticulated
pigmentation on
forehead
Melanoma in situ Lichen planus
pigmentosus
MAþ
S100L
HMB45L
AE±
4 Beltraminelli et al.8 52/F Small scaly plaque of the
infraorbital region
Melanoma in situ Pigmented lichenoid
keratosis
MAþ
S100L
HMB45L
AE±
5 Nicholson et al.9 39/F Recent onset of
hyperpigmented
macules on forehead
Lentigo maligna
melanoma; atypical
junctional melanocytic
neoplasms
Fixed drug eruption
(ibuprofen)
MAþ
S100L
HMB45L
MiTFL
CD68±
CD3±
AE±
6 Nicholson et al.9 76/F Well demarcated
hyperpigmented patch
of right periocular skin
Lentigo maligna
melanoma
Fixed drug eruption
(hydrochlorothiazide)
MAþ
S100L
HMB45L
MiTFL
CD68L
CD3±
AE±
7 Boros et al.
(present case 1)
66/M Solitary pigmented lesion
of facial interdental
papilla between the
mandibular central
incisors, followed by a
solitary pigmented
lesion of buccal gingiva
associated with the left
maxillary second
molar, followed by
pigmented lesions of
right hard palate and
lower lip
Atypical melanocytic
proliferation
Chronic mucositis with
pseudomelanocytic
nests
MA
MiTFL
SOX10L
CD68D
8 Boros et al.
(present case 2)
61/F Solitary pigmented lesion
of hard palate
Rule out atypical
melanocytic
proliferation
Atypical melanotic
process with features
suggestive of
pseudomelanocytic
nests
MA
CD68D
Initial immunohistochemical studies/interpretations are not in bold font; follow-up immunohistochemical studies/interpretations are in
bold font.
IHC, immunohistochemistry; MA, melan-A/MART-1; AE, AE1/AE3; þ, positive; , focally positive; , negative; Bcl2, B-cell CLL/lymphoma 2;
HMB45, human melanoma black 45; MiTF, micropthalmia-associated transcription factor; SOX10, sex-determining region Y box 10; TYR, tyrosinase.
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to determine the frequency of lesions with pseudome-
lanocytic nests. DeMartini and his group published aseries of 132 cases of cutaneous lichen planus and
found no cases containing melan-A/MART-1 positive
pseudomelanocytic nests, supporting the uncommon
OOOO CASE REPORT
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lesions.13 Analysis with additional immunohistochem-
ical markers including CD68 may have also been
insightful. Abuzeid et al.14 analyzed 53 cases of cuta-
neous lupus erythematosus. Among those, 1 of 6 cases
with areas suspicious for pseudomelanocytic nests
showed focal immunoreactivity for MART-1 and MiTF
and lacked immunoreactivity for S100.
In the ﬁrst case presented here, the nested cells
stained strongly positive for CD68. Melan-A in
nested cells was comparable with the negative control.
Focal cytoplasmic staining was present which was
interpreted as non-speciﬁc. Subsequent immunohisto-
chemical evaluation of MiTF and SOX10 was inter-
preted as negative; unfortunately, these slides were not
available for review. Based on the given information,
this is more consistent with a staining pattern of mel-
anophages, as opposed to a pattern of melanocyte
staining. The second case presented also stained
strongly positive for CD68. Immunohistochemical
staining for melan-A was similar to the negative con-
trol (eSlide: VM00242). Again, focal cytoplasmic
staining was present which was interpreted as non-
speciﬁc. MiTF and SOX10 immunostains would also
have been useful but were not used in the evaluation of
the second case because nested cells were diffusely
positive for CD68.
Clinically, the ﬁrst case initially presented as a soli-
tary lesion of the mandibular gingiva, reported to be of
rapid onset. Approximately 2 months later, a second
lesion, this time of the left posterior maxillary buccal
gingiva, was described. In hindsight, this clinical pre-
sentation is more consistent with a reactive process than
a neoplastic process. The patient continues to be fol-
lowed up at regular intervals by the same periodontist.
A follow-up time of more than 3 years has been un-
eventful, with no new or recurrent lesions reported. The
etiology of the lesions remains unknown. Contributing
factors described in the dermatology literature include
lichenoid drug reactions, lichen planus pigmentosus,
discoid lupus erythematosus, and sun damage, the latter
not being applicable to the majority of the oral cavity.
Although no medications were prescribed by the
clinician or reported in the history, it is possible that the
patient was taking medications without disclosure.
Other possibilities of lichenoid inﬂammation include a
reaction to strong ﬂavoring agents, which was not re-
ported and with which the histology was not consistent.
Lichen planus pigmentosus was also considered in the
differential diagnosis; however, this was not supported
clinically, because the ﬁndings from the remainder of
the intraoral examination were within normal limits.
The social history was negative for smoking, which
has also been reported to increase pigmentation in the
oral cavity.The second case presented as a solitary pigmented
lesion of the palate, which could represent either a
reactive or a neoplastic process. In this case, clinical
correlation was not as helpful as in the ﬁrst case. This
patient was also lost to follow-up.
CONCLUSION
The cases presented here represent the ﬁrst 2 cases of
pseudomelanocytic nests reported in the oral pathology
literature. Histologically, pseudomelanocytic nests may
mimic atypical melanocytic proliferations. Clinico-
pathologic correlation has proved helpful to achieve an
accurate diagnosis and, in turn, prevent misdiagnoses
and potential management complications.
The authors thank Dr Jeffrey Waterman, DDS, for contrib-
uting the clinical images.REFERENCES
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